ORGANOGENESIS HOLDINGS INC Share Price Today: Live Updates & Key Insights
ORGANOGENESIS HOLDINGS INC share price today is $2.38, up -0.42%. The stock opened at $2.42 against the previous close of $2.4, with an intraday high of $2.455 and low of $2.375.
ORGANOGENESIS HOLDINGS INC Share Price Chart
ORGANOGENESIS HOLDINGS INC
ORGANOGENESIS HOLDINGS INC Share Price Performance
ORGANOGENESIS HOLDINGS INC Institutional Holdings
ORGANOGENESIS HOLDINGS INC Market Status
ORGANOGENESIS HOLDINGS INC Fundamentals
Market Cap 307.45 M
PB Ratio 1.0244
PE Ratio 15.9333
Enterprise Value 430.98 M
Total Assets 598.73 M
Volume 756975
ORGANOGENESIS HOLDINGS INC Company Financials
About ORGANOGENESIS HOLDINGS INC & investment objective
Company Information Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. Its advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM) scaffolds; Apligraf, a bioengineered bi-layered skin substitute for the treatment of venous leg ulcers and diabetic foot ulcers (DFU); Dermagraft, a dermal substitute grown from human dermal fibroblasts to treat DFUs; NuShield, a dehydrated placental allograft and surgical barrier to provide a protective barrier and ECM scaffold to support native healing; PuraPly Antimicrobial (AM) and PuraPly SX, which are antimicrobial barriers for the management of open wounds in surgical settings; and CYGNUS Dual, VIA Matrix, and SimpliMax are placental tissue grafts used to treat chronic and acute wounds that can be stored at room temperature. The company also provides PuraPly MZ, a micronized version of PuraPly for the management of open wounds in surgical settings; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; FortiShield, a biosynthetic wound matrix for use as a temporary protective covering; and TransCyte, a bioengineered tissue scaffold that promotes burn healing. In addition, it develops ReNu, a cryopreserved suspension, which is in Phase 3 trial, for the management of symptoms associated with knee osteoarthritis; and placental products. The company serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician offices through direct sales representatives and independent agencies. Organogenesis Holdings Inc. is headquartered in Canton, Massachusetts.
Organisation Drug Manufacturers - Specialty & Generic
Employees 854
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Gary S. Gillheeney Sr.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
ORGANOGENESIS HOLDINGS INC FAQs
What is the share price of ORGANOGENESIS HOLDINGS INC today?
The current share price of ORGANOGENESIS HOLDINGS INC is $2.38.
Can I buy ORGANOGENESIS HOLDINGS INC shares in India?
Yes, Indian investors can buy ORGANOGENESIS HOLDINGS INC shares by opening an international trading and demat account with Motilal Oswal.
How to buy ORGANOGENESIS HOLDINGS INC shares in India?
You can easily invest in ORGANOGENESIS HOLDINGS INC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ORGANOGENESIS HOLDINGS INC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ORGANOGENESIS HOLDINGS INC.
Can I buy fractional shares of ORGANOGENESIS HOLDINGS INC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of ORGANOGENESIS HOLDINGS INC?
ORGANOGENESIS HOLDINGS INC has a market cap of $307.45 M.
In which sector does ORGANOGENESIS HOLDINGS INC belong?
ORGANOGENESIS HOLDINGS INC operates in the Drug Manufacturers - Specialty & Generic sector.
What documents are required to invest in ORGANOGENESIS HOLDINGS INC stocks?
To invest, you typically need:
What is the PE and PB ratio of ORGANOGENESIS HOLDINGS INC?
The PE ratio of ORGANOGENESIS HOLDINGS INC is 15.93 and the PB ratio is 1.02.